# Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adjuvant-anti-pd-1-antibody-for-hepatocellular-carcinoma-with-high-recurrence/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Wei Chen,Shuifang Hu,Zelong Liu,Yukun Sun,Jian Wu,Shunli Shen,Zhenwei Peng |
| Citations | 40 |
| DOI | 10.1007/s12072-022-10478-6 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4316662863 |
| PMID | 36645648 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Wei Chen](https://scholariq.org/researchers/wei-chen-5/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.